MX2018001117A - Composiciones nutricionales con 2fl y lnnt para usar en la induccion de una microbiota intestinal cercana a la de los infantes alimentados por lactancia materna. - Google Patents

Composiciones nutricionales con 2fl y lnnt para usar en la induccion de una microbiota intestinal cercana a la de los infantes alimentados por lactancia materna.

Info

Publication number
MX2018001117A
MX2018001117A MX2018001117A MX2018001117A MX2018001117A MX 2018001117 A MX2018001117 A MX 2018001117A MX 2018001117 A MX2018001117 A MX 2018001117A MX 2018001117 A MX2018001117 A MX 2018001117A MX 2018001117 A MX2018001117 A MX 2018001117A
Authority
MX
Mexico
Prior art keywords
inducing
gut microbiota
lnnt
infants
nutritional compositions
Prior art date
Application number
MX2018001117A
Other languages
English (en)
Inventor
Sprenger Norbert
Berger Bernard
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53773387&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2018001117(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2018001117A publication Critical patent/MX2018001117A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/12—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/08—Deoxysugars; Unsaturated sugars; Osones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Pediatric Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La presente invención se refiere a una composición nutricional que comprende al menos un oligosacárido fucosilado y al menos un oligosacárido N-acetilado para promover o inducir una microbiota intestinal global más cercana a la de los infantes alimentados exclusivamente con leche materna humana, en comparación con los infantes alimentados con una composición nutricional convencional. La composición puede ser una fórmula para infantes y, en particular, está destinada a infantes de entre 0 y 12 meses alimentados predominantemente con fórmula para infantes. Promueve una flora intestinal saludable y tiene efectos beneficiosos a corto y largo plazo.
MX2018001117A 2015-08-04 2016-08-04 Composiciones nutricionales con 2fl y lnnt para usar en la induccion de una microbiota intestinal cercana a la de los infantes alimentados por lactancia materna. MX2018001117A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15179742 2015-08-04
PCT/EP2016/068597 WO2017021476A1 (en) 2015-08-04 2016-08-04 Nutritional compositions with 2fl and lnnt for use in inducing a gut microbiota close to the one of breast fed infants

Publications (1)

Publication Number Publication Date
MX2018001117A true MX2018001117A (es) 2018-04-20

Family

ID=53773387

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018001117A MX2018001117A (es) 2015-08-04 2016-08-04 Composiciones nutricionales con 2fl y lnnt para usar en la induccion de una microbiota intestinal cercana a la de los infantes alimentados por lactancia materna.

Country Status (9)

Country Link
US (1) US20180220690A1 (es)
EP (1) EP3331534B1 (es)
CN (1) CN107847509B (es)
AU (1) AU2016303000B2 (es)
ES (1) ES2772685T3 (es)
MX (1) MX2018001117A (es)
PH (1) PH12017502350A1 (es)
RU (1) RU2724590C2 (es)
WO (1) WO2017021476A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3212012A1 (en) 2014-10-31 2017-09-06 Nestec S.A. Composition comprising fut2-dependent oligosaccharides and lacto-n-neotetraose for use in promoting brain development and cognition
MX2017010923A (es) * 2015-03-05 2018-01-16 Nestec Sa Composiciones para usar en el mejoramiento de la consistencia o la frecuencia de las heces en infantes o niños pequeños.
ES2947458T3 (es) * 2015-03-05 2023-08-09 Nestle Sa Composiciones para su uso en la prevención o el tratamiento de infecciones gastrointestinales en lactantes o niños pequeños
CN109640702A (zh) 2016-09-07 2019-04-16 雀巢产品技术援助有限公司 用于婴儿和/或幼儿的包含低聚糖的营养组合物
US11065217B2 (en) 2017-01-27 2021-07-20 Temple University—Of the Commonwealth System of Higher Education Use of short chain fatty acids for the treatment and prevention of diseases and disorders
WO2018157900A1 (en) * 2017-03-01 2018-09-07 Glycom A/S Synthetic composition for microbiota modulation
US20180333426A1 (en) * 2017-05-17 2018-11-22 Mead Johnson Nutrition Company Nutritional composition with human milk oligosaccharides and uses thereof
WO2019008102A1 (en) * 2017-07-07 2019-01-10 Nestec S.A. FORTIFYING HUMAN MILK
BR112020009257A2 (pt) * 2017-12-21 2020-10-20 Société des Produits Nestlé S.A. composições que compreendem pelo menos um oligossacarídeo n-acetilado e pelo menos um oligossacarídeo fucosilado para uso na promoção da capacidade digestiva em bebês e crianças pequenas
CN112384227A (zh) 2018-02-09 2021-02-19 N·V·努特里奇亚 含有不可消化寡糖的发酵配方物
EP3749328A1 (en) 2018-02-09 2020-12-16 N.V. Nutricia Fermented formula with non-digestible oligosaccharides
GB2573538B (en) * 2018-05-09 2023-01-04 Mjn Us Holdings Llc Pediatric nutritional compositions and methods for infants delivered by C-section
CN110839702A (zh) * 2018-08-21 2020-02-28 内蒙古伊利实业集团股份有限公司 一种改善婴幼儿肠道菌群丰度和粪便气味的母乳低聚糖组合物及其应用
FR3099770B1 (fr) * 2019-08-05 2023-01-13 Luxia Scient Methode d’analyse de la perte de diversite bacterienne du microbiome intestinal humain
CN112075637B (zh) * 2020-04-27 2023-05-23 合生元（广州）健康产品有限公司 一种减少肠道气体产生的组合物
CN111437282A (zh) * 2020-04-28 2020-07-24 南开大学 2′-岩藻糖基乳糖减少大肠杆菌o157在体内定殖的应用
AU2021359712A1 (en) * 2020-10-16 2023-03-23 Société des Produits Nestlé S. A. Infant or young child formula
JP2023546794A (ja) * 2020-10-28 2023-11-08 ディーエスエム アイピー アセッツ ビー．ブイ． 抗生物質に曝露した後で腸内マイクロバイオームのバランス回復のためのビタミンの直接的送達
AU2021377524A1 (en) * 2020-11-16 2023-07-06 Inner Mongolia Dairy Tech Res Institute Co Ltd Composition containing bifidobacterium lactis and human milk oligosaccharides and application thereof
CN112514997B (zh) * 2020-11-30 2022-03-11 内蒙古伊利实业集团股份有限公司 改善肠道微环境健康的母乳低聚糖及其应用
CN113796546A (zh) * 2021-09-13 2021-12-17 合生元（广州）健康产品有限公司 改善肠道屏障功能母乳低聚糖组合物及其应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6045854A (en) * 1997-03-31 2000-04-04 Abbott Laboraties Nutritional formulations containing oligosaccharides
US5906982A (en) 1997-03-31 1999-05-25 Abbott Laboratories Nutritional formulations containing Lacto-N-neoTetraose
BRPI0708701A2 (pt) * 2006-03-10 2011-06-07 Nutricia Nv uso de um sacarìdeo não digerìvel solúvel em água
MY159076A (en) * 2007-11-08 2016-12-15 Nestec Sa Use of oligosaccharides containing n-acetyllactosamine for maturation of immune responses in neonates
ES2611203T3 (es) 2007-12-21 2017-05-05 N.V. Nutricia Uso de esfingomielina y carbohidratos no digeribles para mejorar la microbiota intestinal
BRPI0912106A2 (pt) * 2008-05-27 2015-10-13 Nestec Sa probióticos para melhorar a microbiota intestinal
US8425955B2 (en) 2009-02-12 2013-04-23 Mead Johnson Nutrition Company Nutritional composition with prebiotic component
EP2454948A1 (en) 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
EP2465508A1 (en) * 2010-11-23 2012-06-20 Nestec S.A. Composition comprising hydrolysed proteins and oligosaccharides for treating skin diseases
EP2455387A1 (en) * 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
EP3335577A1 (en) * 2010-12-31 2018-06-20 Abbott Laboratories Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota
SG10202110501RA (en) 2010-12-31 2021-11-29 Abbott Lab Methods For Decreasing The Incidence Of Necrotizing Enterocolitis In Infants, Toddlers, Or Children Using Human Milk Oligosaccharides
JP6129821B2 (ja) * 2011-05-13 2017-05-17 グリコシン リミテッド ライアビリティー カンパニー プレバイオティクスとしての、精製された２’−フコシルラクトース、３−フコシルラクトース、およびラクトジフコテトラオースの使用
EP2522232A1 (en) * 2011-05-13 2012-11-14 Nestec S.A. Nutritional products comprising human milk oligosaccharides and methods for manufacture thereof
KR20140036226A (ko) 2011-05-13 2014-03-25 글리콤 에이/에스 모유 올리고사카라이드(hmo) 또는 그의 전구체의 다양화
EP3095331A1 (en) * 2011-10-18 2016-11-23 Nestec S.A. Composition for use in brain growth and/or cognitive and/or psychomotor development
MX350870B (es) * 2011-11-10 2017-09-22 Nestec Sa Formula para lactantes con alto palmitato sn-2 y oligofructosa.
EP2861609A4 (en) 2012-06-14 2015-11-04 Glycom As IMPROVING STABILITY AND PURITY AND INCREASING THE BIOAVAILABILITY OF HUMAN MILK OLIGOSACCHARIDES OR PRECURSORS OR MIXTURES THEREOF
MX2016006060A (es) * 2013-11-15 2016-08-03 Nestec Sa Composiciones para usar en la prevencion o tratamiento de la enterocolitis necrotizante en infantes y niños pequeños.
US11135232B2 (en) * 2013-11-15 2021-10-05 Societe Des Produits Nestle S.A. Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children
MX2017010923A (es) * 2015-03-05 2018-01-16 Nestec Sa Composiciones para usar en el mejoramiento de la consistencia o la frecuencia de las heces en infantes o niños pequeños.

Also Published As

Publication number Publication date
PH12017502350A1 (en) 2018-06-25
AU2016303000A1 (en) 2017-12-21
RU2018107583A (ru) 2019-09-05
RU2018107583A3 (es) 2019-12-05
US20180220690A1 (en) 2018-08-09
EP3331534A1 (en) 2018-06-13
EP3331534B1 (en) 2019-12-18
CN107847509A (zh) 2018-03-27
CN107847509B (zh) 2021-06-01
ES2772685T3 (es) 2020-07-08
AU2016303000B2 (en) 2021-01-21
RU2724590C2 (ru) 2020-06-25
WO2017021476A1 (en) 2017-02-09

Similar Documents

Publication Publication Date Title
PH12017502350A1 (en) Nutritional compositions with 2fl and lnnt for use in inducing a gut microbiota close to the one of breast fed infants
PH12018502383A1 (en) Nutritional compositions with 2fl and lnnt for use in preventing and/or treating non-rotavirus diarrhea by acting on the gut microbiota dysbiosis
PH12017502182A1 (en) Nutritional compositions and infant formulas comprising bifidobacterium animalis ssp. lactis and optionally a mix of oligosaccharides for inducing a gut microbiota close to the one of breast fed infants
PH12016500762A1 (en) Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children
PH12017550040A1 (en) Compositions for use in the prevention or treatment of gastrointestinal infections/inflammations in infants or young children
PH12016500764B1 (en) Compositions for use in the prevention or treatment of urt infections in infants or young children at risk
PH12017550044A1 (en) Compositions for use in the prevention or treatment of otitis or bronchitis in infants or young children
MX2017003441A (es) Sistema de formulas infantiles con niveles adaptables de oligosacaridos de la leche humana (hmo).
PH12018501328A1 (en) Compositions comprising 2fl and lnnt for use in infants or young children to prevent later in life obesity or related comorbidities
PH12018501298A1 (en) Human milk oligosaccharides for health benefits by prevention of premature adiposity rebound
PH12017550041A1 (en) Compositions for use in improving stool consistency or frequency in infants or young children
PH12018501324A1 (en) COMPOSITIONS COMPRISING 2FL AND LNnT TO CONTROL FOOD INTAKE AND GROWTH IN INFANTS OR YOUNG CHILDREN
PH12019550168A1 (en) Composition comprising human milk oligosaccharides (hmo) for use in the improvement of short term memory and other cognitive benefits
PH12016500774A1 (en) Nutritional composition for use in reducing metabolic stress in infants, decreasing gut permeability and approximating growth rate of breast-fed infants
NZ771554A (en) Nutritional composition for promoting intestinal health
PH12019500799A1 (en) Personalized pediatric nutrition products comprising human milk oligosaccharides
PH12018502382A1 (en) Nutritional compositions and infant formulas comprising a mix of oligosaccharides and optionally bifidobacterium lactis for preventing, treating or reducing the severity of non-rotavirus-associated diarrhoea
PH12018501262A1 (en) Compositions comprising human milk oligosaccharides for use in infants or young children to prevent or treat allergies
PH12020550465A1 (en) Compositions comprising at least one n-acetylated and at least one fucosylated oligosaccharide for use in the promotion of digestive capacity in infants and young children
PH12019500092A1 (en) Nutritional compositions for infants and/or young children comprising oligosaccharides
MX2020001840A (es) Administracion de vitamina b2 materna para la prevencion del aumento de la adiposidad, el sobrepeso o la obesidad en la descendencia.
PH12018501150A1 (en) Nutritional compositions and infant formulas containing relatively high level of oligofructose for inducing gut microbiota patterns close to those of human milk fed infants
NZ626573A (en) Glutamine enriched nutritional composition for preterm infants
Thum Gut microbiota determined by what we eat and what we inherit
TH158882B (th) องค์ประกอบสำหรับใช้ในการป้องกันหรือรักษาการติดเชื้อ urt ในทารกหรือเด็ก เล็กที่มีความเสี่ยง